Gestational hypertension

American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia. Obstet Gynecol. 2019 Jan;133(1):e1-25. Abstract

Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003 Jul;102(1):181-92. Abstract

American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia. Obstet Gynecol. 2019 Jan;133(1):e1-25. Abstract

1. American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia. Obstet Gynecol. 2019 Jan;133(1):e1-25. Abstract

2. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003 Jul;102(1):181-92. Abstract

3. Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018 Jul;13:291-310. Abstract

4. Gregg AR. Hypertension in pregnancy. Obstet Gynecol Clin North Am. 2004 Jun;31(2):223-41;v. Abstract

5. Department of Health. NHS maternity statistics, England 2018-19. October 2019 [internet publication]Full text

6. Committee on Technical Bulletins of the American Congress of Obstetricians and Gynecologists. ACOG technical bulletin. Hypertension in pregnancy. Number 219 - January 1996. Int J Gynaecol Obstet. 1996 May;53(2):175-83. Abstract

7. Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in severe preeclampsia. Am J Obstet Gynecol. 2002;186:66-71. Abstract

8. Savitz DA, Danilack VA, Engel SM, et al. Descriptive epidemiology of chronic hypertension, gestational hypertension, and preeclampsia in New York State, 1995-2004. Matern Child Health J. 2014 May;18(4):829-38. Abstract

9. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol. 2000 Jan;95(1):24-8. Abstract

10. Knuist M, Bonsel GJ, Zondervan HA, et al. Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders. Int J Gynaecol Obstet. 1998 May;61(2):127-33. Abstract

11. Hnat MD, Sibai BM, Caritis S, et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol. 2002 Mar;186(3):422-6. [Erratum in: Am J Obstet Gynecol. 2003 Jul;189(1):244.] Abstract

12. Bryant AS, Seely EW, Cohen A, et al. Patterns of pregnancy-related hypertension in black and white women. Hypertens Pregnancy. 2005;24(3):281-90. Abstract

13. Tanaka M, Jaamaa G, Kaiser M, et al. Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health. 2007 Jan;97(1):163-70.Full text  Abstract

14. Innes KE, Wimsatt JH, McDuffie R. Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol. 2001;97:905-10.Full text  Abstract

15. Vidaeff AC, Carroll MA, Ramin SM. Acute hypertensive emergencies in pregnancies. Crit Care Med. 2005 Oct;33(suppl 10):S307-12. Abstract

16. Wolf M, Sandler L, Jimenez-Kimble R, et al. Insulin resistance but not inflammation is associated with gestational hypertension. Hypertension. 2002 Dec;40(6):886-91.Full text  Abstract

17. Lombardi DG, Barton JR, O'Brien JM, et al. Does an obese prepregnancy body mass index influence outcome in pregnancies complicated by mild gestational hypertension remote from term? Am J Obstet Gynecol. 2005 May;192(5):1472-4. Abstract

18. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1997 Nov;177(5):1003-10. Abstract

19. Michlin R, Oettinger M, Odeh M, et al. Maternal obesity and pregnancy outcome. Isr Med Assoc J. 2000 Jan;2(1):10-3.Full text  Abstract

20. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):642-8. Abstract

21. Rasmussen S, Irgens LM. Pregnancy-induced hypertension in women who were born small. Hypertension. 2007 Apr;49(4):806-12.Full text  Abstract

22. Bismuth E, Bouche C, Caliman C, et al. Management of pregnancy in women with type 1 diabetes mellitus: guidelines of the French-Speaking Diabetes Society (Société francophone du diabète [SFD]). Diabetes Metab. 2012 Jun;38(3):205-16. Abstract

23. Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009 Mar;29(3):286-92. Abstract

24. Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG. 2007 Aug;114(8):933-43.Full text  Abstract

25. Imdad A, Jabeen A, Bhutta ZA. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. BMC Public Health. 2011 Apr 13;11(suppl 3):S18.Full text  Abstract

26. Ronsmans C, Campbell O. Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy. BMC Public Health. 2011 Apr 13;11(suppl 3):S8.Full text  Abstract

27. mdad A, Bhutta ZA. Effects of calcium supplementation during pregnancy on maternal, fetal and birth outcomes. Paediatr Perinat Epidemiol. 2012 Jul;26(suppl 1):138-52.Full text  Abstract

28. Hofmeyr GJ, Lawrie TA, Atallah ÁN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018 Oct 1;10:CD001059.Full text  Abstract

29. Bujold E, Morency AM, Roberge S, et al. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2009 Sep;31(9):818-26. Abstract

30. Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007 May 26;369(9575):1791-8. Abstract

31. Roberge S, Nicolaides K, Demers S, et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017 Feb;216(2):110-20.e6. Abstract

32. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. NG133. June 2019 [internet publication].Full text

33. oberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010 Apr 8;362(14):1282-91.Full text  Abstract

34. Bergel E, Carroli G, Althabe F. Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. Cochrane Database Syst Rev. 2002;(2):CD001231.Full text  Abstract

35. Brown MA, Roberts LM, Mackenzie C, et al. A prospective randomized study of automated versus mercury blood pressure recordings in hypertensive pregnancy (PRAM Study). Hypertens Pregnancy. 2012;31(1):107-19. Abstract

36. Hillier TA, Vesco KK, Pedula KL, et al. Screening for gestational diabetes mellitus: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2008 May 20;148(10):766-75.Full text  Abstract

37. National Institute for Health and Care Excellence. Antenatal care for uncomplicated pregnancies. CG62. February 2019 [internet publication].Full text

38. Broekhuijsen K, van Baaren GJ, van Pampus MG, et al; HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2492-501. Abstract

39. Cluver C, Novikova N, Koopmans CM, et al. Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term. Cochrane Database Syst Rev. 2017;(1):CD009273.Full text  Abstract

40. Dowswell T, Middleton P, Weeks A. Antenatal day care units versus hospital admission for women with complicated pregnancy. Cochrane Database Syst Rev. 2009;(4):CD001803.Full text  Abstract

41. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. NG133. June 2019 [internet publication].Full text

42. Kiel DW, Dodson EA, Artal R, et al. Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstet Gynecol. 2007 Oct;110(4):752-8. Abstract

43. Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018 Oct 1;10:CD002252.Full text  Abstract

44. American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia. Obstet Gynecol. 2019 Jan;133(1):e1-25. Abstract

45. ACOG Committee Opinion no. 767. Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2019 Feb;133(2):e174-e180. Abstract

46. Tuffnell DJ, Jankowicz D, Lindow SW, et al. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG. 2005 Jul;112(7):875-80.Full text  Abstract

47. Shekhar S, Gupta N, Kirubakaran R, et al. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG. 2016 Jan;123(1):40-7.Full text  Abstract

48. ACOG practice bulletin no. 203. Chronic hypertension in pregnancy. Obstet Gynecol. 2019 Jan;133(1):e26-e50. Abstract

49. Gilbert GE, Wahlquist AH, eds. InfoPOEMs: induction of labor may be beneficial at 36 weeks with hypertension. J Natl Med Assoc. 2010;102:151-2.

50. Raheem IA, Saaid R, Omar SZ, et al. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG. 2012 Jan;119(1):78-85.Full text  Abstract

51. Medicines and Healthcare products Regulatory Agency. Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy. May 2019 [internet publication].Full text

52. US Food and Drug Administration. FDA drug safety communication: FDA recommends against prolonged use of magnesium sulfate to stop preterm labor due to bone changes in exposed babies. May 2013 [internet publication].Full text

53. Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017 Mar;40(3):213-20. Abstract

54. Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009;122:890-895. Abstract

55. Barton CB, Barton JR, O'Brien JM, et al. Mild gestational hypertension: differences in ethnicity are associated with altered outcomes in women who undergo outpatient treatment. Am J Obstet Gynecol. 2002 May;186(5):896-8. Abstract

56. Petersen EE, Davis NL, Goodman D, et al. Racial/ethnic disparities in pregnancy-related deaths - United States, 2007-2016. MMWR Morb Mortal Wkly Rep. 2019 Sep 6;68(35):762-5.Full text  Abstract

57. Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019 Aug;105(16):1273-8.Full text  Abstract

58. Paridisi G, Biaggi A, Savone R, et al. Cardiovascular risk factors in healthy women with previous gestational hypertension. J Clin Endocrinol Metab. 2006 Apr;91(4):1233-8.Full text  Abstract

59. Forrester KJ, Barton JR, O'Brien JM, et al. The effect of gestational hypertension and gestational diabetes on neonatal outcome. Obstet Gynecol. 2006;107(suppl 4):26S.

60. Sep S, Smits L, Prins M, et al. Prediction tests for recurrent hypertensive disease in pregnancy, a systematic review. Hypertens Pregnancy. 2010 Jan;29(2):206-30. Abstract

61. Tucker KL, Taylor KS, Crawford C, et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study. BMC Pregnancy Childbirth. 2017 Dec 28;17(1):442.Full text  Abstract

62. Tucker KL, Bowen L, Crawford C, et al. The feasibility and acceptability of self-testing for proteinuria during pregnancy: A mixed methods approach. Pregnancy Hypertens. 2018 Apr;12:161-8.Full text  Abstract

63. Timpka S, Stuart JJ, Tanz LJ, et al. Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses' Health Study II: observational cohort study. BMJ. 2017 Jul 12;358:j3024.Full text  Abstract

64. Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database Syst Rev. 2005;(4):CD003514.Full text  Abstract